These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32501862)

  • 21. Modifiable Factors Associated with Non-Adherence to Secondary Ischaemic Stroke Prevention Strategies.
    Shankari G; Ng SC; Goh SY; Woon FP; Doshi K; Wong PS; Fan Q; Tan IF; Narasimhalu K; De Silva DA
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105395. PubMed ID: 33254378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clustering of lifestyle characteristics and their association with cardio-metabolic health: the Lifestyles and Endothelial Dysfunction (EVIDENT) study.
    Patino-Alonso MC; Recio-Rodríguez JI; Magdalena-Belio JF; Giné-Garriga M; Martínez-Vizcaino V; Fernández-Alonso C; Arietaleanizbeaskoa MS; Galindo-Villardon MP; Gómez-Marcos MA; García-Ortiz L;
    Br J Nutr; 2015 Sep; 114(6):943-51. PubMed ID: 26268844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
    Rodriguez F; Cannon CP; Steg PG; Kumbhani DJ; Goto S; Smith SC; Eagle KA; Ohman EM; Umez-Eronini AA; Hoffman E; Bhatt DL;
    Clin Cardiol; 2013 Dec; 36(12):721-7. PubMed ID: 24166484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial.
    Olomu A; Kelly-Blake K; Hart-Davidson W; Gardiner J; Luo Z; Heisler M; Holmes-Rovner M
    Trials; 2022 Aug; 23(1):659. PubMed ID: 35971135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.
    Packard KA; Hilleman DE
    Cardiovasc Ther; 2016 Dec; 34(6):415-422. PubMed ID: 27473898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
    J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review.
    Lopez-Lopez JP; Gonzalez AM; Lanza P; Lopez-Jaramillo P
    Vasc Health Risk Manag; 2023; 19():605-615. PubMed ID: 37719697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 31. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster analysis of medication adherence in Pacific patients with high cardiovascular risk.
    Warren J; Gu Y; Kennelly J
    Stud Health Technol Inform; 2014; 204():169-75. PubMed ID: 25087545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
    Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
    JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B; He X; Wu J; Yan S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study.
    Shalaeva EV; Bano A; Kasimov U; Janabaev B; Laimer M; Saner H
    Glob Heart; 2023; 18(1):61. PubMed ID: 37928361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
    Abughosh SM; Vadhariya A; Johnson ML; Essien EJ; Esse TW; Serna O; Gallardo E; Boklage SH; Choi J; Holstad MM; Fleming ML
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden.
    Karlsson SA; Eliasson B; Franzén S; Miftaraj M; Svensson AM; Andersson Sundell K
    BMJ Open Diabetes Res Care; 2019; 7(1):e000639. PubMed ID: 31114701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
    Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.